We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

7 hedge funds and large institutions have $3.38M invested in VolitionRx Ltd in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0.19% less ownership

Funds ownership: 4.96% → 4.77% (-0.19%)

30% less funds holding

Funds holding: 10 → 7 (-3)

93% less capital inflows, than outflows

Capital inflows: $10.5K | Capital outflows: $154K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$6.73K
2
Morgan Stanley
Morgan Stanley
New York
+$3.78K

Top Sellers

Rank Fund Capital Flow
1
Virtu KCG Holdings
Virtu KCG Holdings
New York
-$82K
2
Spark Investment Management
Spark Investment Management
New York
-$72K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$151

VNRX Hedge Fund Activity: Q2 2015 in Review

7 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2015, worth a combined $3.38M — down 7.7% from $3.66M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VNRX and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was UBS Group, adding an estimated $6.73K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $82K sold.

  • 7 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2015, down from 10 in Q1 2015.
  • Funds reported $3.38M of VolitionRx Ltd stock for Q2 2015, down 7.7% quarter-over-quarter.
  • 0 funds opened new VolitionRx Ltd positions in Q2 2015 and 3 closed out, a net change of -3 holders.
  • The largest VolitionRx Ltd buyer in Q2 2015 was UBS Group, an estimated $6.73K added.
  • The largest VolitionRx Ltd seller in Q2 2015 was Virtu KCG Holdings, an estimated $82K sold.

Based on aggregated 13F filings for Q2 2015.